Brooklyn Immunotherapeutics Inc expected to post a loss of 12  cents a share - Earnings Preview

Ernexa Therapeutics

23/03/2022 11:03

* Brooklyn Immunotherapeutics Inc  BTX.OQ   BTX.O  is
expected
to report results on March 25 (estimated).
    * ​Refinitiv's mean analyst estimate for Brooklyn
Immunotherapeutics Inc is for a loss of 12 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Brooklyn
Immunotherapeutics Inc is $9​, above​ its last closing price
of $2.12. ​​​

This summary was machine generated March 23 at 11:03 GMT.  All
figures in US dollars  unless otherwise stated